Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Companies  >  All News

News : Companies

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immunomedics Inc. – IMMU

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/11/2019 | 07:56pm EST

NEW YORK, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Immunomedics Inc. (“Immunomedics” or the “Company”) (NASDAQ:  IMMU).  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

 [Click here to join a class action]

The investigation concerns whether Immunomedics and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. 

On December 17, 2018, FDAnews.com published an article entitled “FDA Hits Immunomedics for Data Integrity Breach.”  The article reported, in part, that “[t]he FDA cited Immunomedics for a host of violations—including its handling of a data integrity breach—observed at its Morris Plains, New Jersey, drug substance manufacturing facility between August 6 and 14.”  The article further stated that the data breach included “manipulated bioburden samples, misrepresentation of an integrity test procedure in the batch record, and backdating of batch records, such as dates of analytical results.”  Following publication of this article, Immunomedics’ stock price fell sharply, damaging investors.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com


© GlobeNewswire 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news "Companies"
07:05pNW Natural Holdings Announces Dividend
GL
07:04p21ST CENTURY FOX : Announces Pricing of Senior Notes by Fox Corporation
PR
07:04pYRIV $100K NOTICE : Rosen Law Firm Reminds Yangtze River Port and Logistics Limited Investors of Important Deadline in First Filed Class Action - YRIV
PR
07:01pDESERT LION ENERGY : Interest Payment of Convertible Promissory Notes
AQ
07:01pSEASPAN : Announces Closing of Second $500 Million Investment by Fairfax Financial Holdings Limited
PR
07:01pTHE NEW HOME COMPANY : Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call
BU
07:01pBig Banks Find Sweet Spot in Higher Rates -- Update
DJ
07:01piSIGN Media Announces A Promissory Note Extension and Related Interest Terms
GL
06:50pWESTERN TROY CAPITAL RES : CORRECTING and REPLACING – Western Troy Capital Resources Inc.
AQ
06:49pPAYLOCITY : Recognized as One of G2 Crowd's Best Software Companies
PU
Latest news "Companies"
Advertisement